Aegerion Pharmaceuticals Announces Third Quarter 2012 Financial Results

[at noodls] – CAMBRIDGE, Mass., Nov. 7, 2012 (GLOBE NEWSWIRE) — Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics … more

View todays social media effects on AEGR

View the latest stocks trending across Twitter. Click to view dashboard